Jeffrey Yoshida, M.D., is the program director of urologic oncology at
Hoag Family Cancer Institute. As program director, Dr. Yoshida plays a
key role in the growth of site-specific programs for urologic malignancies,
which include prostate, kidney, bladder and testicular cancers. Dr. Yoshida
is an expert in robotic surgery having performed over 2,200 surgeries
to date. He has extensive experience in robotic-assisted radical prostatectomy
(prostate removal), radical nephrectomy (kidney removal) and partial nephrectomy.
Dr. Yoshida’s primary focus is to lead the development of a comprehensive,
multidisciplinary prostate cancer program. He chairs the multidisciplinary
prostate/urologic oncology case conferences that are held twice a month
at Hoag Family Cancer Institute. With his knowledge and experience in
robotic surgery, Dr. Yoshida expands Hoag Hospital’s capabilities
in minimally invasive robotic surgery.
Dr. Yoshida is board-certified in urology and has practiced as a urologic
oncologist since 2004. He received his undergraduate degree in biology
from Pacific Union College and earned his medical degree from Loma Linda
University. He completed an internship in general surgery at Harbor-UCLA
and a residency in urology at Loma Linda University. Dr. Yoshida then
completed a fellowship in urologic oncology/robotic surgery at City of
Hope Medical Center, a National Family Cancer Institute-designated Comprehensive
Cancer Center in Duarte, California. While at City of Hope, he served
as assistant clinical professor in the department of urologic oncology
and also held a surgical leadership role in the kidney cancer program.
Dr. Yoshida was author of the article titled “Robot-Assisted Laparoscopic
Nephrectomy: How Its Technical Precision is Reshaping Minimally Invasive
Surgery,” which was published in Kidney Cancer Journal in April, 2008.